Proteomic characterization of novel alternative splice variant proteins in human epidermal growth factor receptor 2/neu-induced breast cancers

Cancer Research

Volumn 70, Issue 9, 2010, Pages 3440-3449

  Menon, Rajasree ^a   Omenn, Gilbert S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; DOXYCYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MESSENGER RNA; PROTEIN KINASE;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER GROWTH; CELL MOTILITY; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MAMMARY GLAND; MASS SPECTROMETRY; MOUSE; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; TANDEM MASS SPECTROMETRY; TRANSLATION INITIATION; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MOLECULAR SEQUENCE DATA; PROTEIN ISOFORMS; PROTEOMICS; RECEPTOR, ERBB-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TANDEM MASS SPECTROMETRY; UP-REGULATION;

EID: 77951718967     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-2631     Document Type: Article

References (50)

1. Bracco L, Kearsey J. The relevance of alternative RNA splicing to pharmacogenomics. Trends Biotechnol 2003;21:346-353 (Pubitemid 37281269)
2. Faustino NA, Cooper TA. Pre-mRNA splicing and human disease. Genes Dev 2003;17:419-437
3. Garcia-Blanco MA, Baraniak AP, Lasda EL. Alternative splicing in disease and therapy. Nat Biotech 2004;22:535-546
4. Venables JP, Klinck R, Bramard A, et al. Identification of alternative splicing markers for breast cancer. Cancer Res 2008;68:9525-9531 (Pubitemid 351206740)
5. Fermin D, Allen B, Blackwell T, et al. Novel gene and gene model detection using a whole genome open reading frame analysis in proteomics. Genome Biol 2006;7:R35. (Pubitemid 43871876)
6. Menon R, Zhang Q, Zhang Y, et al. Identification of novel alternative splice isoforms of circulating proteins in a mouse model of human pancreatic cancer. Cancer Res 2009;69:300-309
7. Whiteaker JR, Zhang H, Zhao L, et al. Integrated pipeline for mass spectrometry-based discovery and confirmation of biomarkers demonstrated in a mouse model of breast cancer. J Proteome Res 2007; 6:3962-3975 (Pubitemid 350032560)
8. PeptideAtlas. 2009 (cited; Available from: http://www.peptideatlas.org/ repository/).
9. Craig R, Beavis RC. TANDEM: matching proteins with tandem mass spectra. Bioinformatics 2004;20:1466-1467 (Pubitemid 38931421)
10. The Eukaryotic Linear Motif resource for Functional Sites in Proteins: Functional site prediction. 2009 (cited; Available from: http://elm.eu.org/).
11. MyHits: MotifScan. 2009 (cited; Available from: http://myhits.isb-sib.ch/ cgi-bin/motif-scan).
12. Berkeley Drosophila Genome Project: Splice Site Prediction by Neural Network 2008 (cited; Available from: http://www.fruitfly.org/seq-tools/splice. html).
13. Ambatipudi KS, Lu B, Hagen FK, Melvin JE, Yates JR. Quantitative analysis of age specific variation in the abundance of human female parotid salivary proteins. J Proteome Res 2009;8:5093-5102
14. Nikolsky Y, Ekins S, Nikolskaya T, Bugrim A. A novel method for generation of signature networks as biomarkers from complex high throughput data. Toxicol Lett 2005;158:20-29 (Pubitemid 40910724)
15. Gao J, Ade AS, Tarcea VG, et al. Integrating and annotating the interactome using the MiMI plugin for cytoscape. Bioinformatics 2009;25:137-138
16. Bonifacino JS, Dell'Angelica EC. Molecular bases for the recognition of tyrosine-based sorting signals. J Cell Biol 1999;145:923-926
17. Gilboa L, Ben-Levy R, Yarden Y, Henis YI. Roles for a cytoplasmic tyrosine and tyrosine kinase activity in the interactions of neu receptors with coated pits. J Biol Chem 1995;270:7061-7067
18. Cicenas J, Urban P, Vuaroqueaux V, et al. Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2. Breast Cancer Res 2005;7:R394-R401.
19. Lee MY, Joung YH, Lim EJ, et al. Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells. Breast 2006;15: 187-195
20. Wang H, Hubbell E, Hu J-s, et al. Gene structure-based splice variant deconvolution using a microarry platform. Bioinformatics 2003;19: i315-22.
21. Trembley J, Wang G, Unger G, Slaton J, Ahmed K. Protein kinase CK2 in health and disease. Cell Mol Life Sci 2009;66:1858-1867
22. Shrivastav A, Pasha MK, Selvakumar P, et al. Potent inhibitor of N-myristoylation: a novel molecular target for cancer. Cancer Res 2003;63:7975-7978 (Pubitemid 37466735)
23. Mackay HJ, Twelves CJ. Protein kinase C: a target for anticancer drugs? Endocr Relat Cancer 2003;10:389-396
24. Takahashi K, Sasaki T, Mammoto A, et al. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J Biol Chem 1997;272: 23371-23375 (Pubitemid 27392478)
25. Daisuke Y, Shusaku K, Tadaomi T. Regulation of cancer cell motility through actin reorganization. Cancer Sci 2005;96:379-386 (Pubitemid 41179738)
26. Fritz G, Brachetti C, Bahlmann F, Schmidt M, Kaina B. Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer 2002;87:635-644
27. Fernando H, Martin TA, Douglas-Jones A, Kynaston HG, Mancel RE, Jiang WG. Expression of the ERM family members (ezrin, radixin and moesin) in breast cancer. Exp Ther Med 2010;1:153-160
28. Ellenbroek S, Collard J. Rho GTPases: functions and association with cancer. Clin Exp Metastasis 2007;24:657-672
29. Tucker LA, Zhang Q, Sheppard GS, et al. Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation. Oncogene 2008;27:3967-3976 (Pubitemid 351913632)
30. Lauffenburger DA, Horwitz AF. Cell migration: a physically integrated molecular process. Cell 1996;84:359-369
31. Bracke ME, Maeseneer D, Marck V, et al. Cell motility and breast cancer metastasis. Metastasis Breast Cancer 2007:47-75.
32. Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett 2008;582:2093-2101
33. Forget MA, Desrosiers RR, Gingras D, Beliveau R. Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem J 2002;361:243-254 (Pubitemid 34174491)
34. Greene LM, Twal WO, Duffy MJ, et al. Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br J Cancer 2003;88:871-878 (Pubitemid 36520874)
35. Swartling FJ, Ferletta M, Kastemar M, Weiss WA, Westermark B. Cyclic GMP-dependent protein kinase II inhibits cell proliferation, Sox9 expression and Akt phosphorylation in human glioma cell lines. Oncogene 2009;28:3121-3131
36. Luscher B, Kuenzel EA, Krebs EG, Eisenman RN. Myc oncoproteins are phosphorylated by casein kinase II. EMBO J 1989;8:1111-1119 (Pubitemid 19273278)
37. Boyle DM, van der Walt LA. Enhanced phosphorylation of progesterone receptor by protein kinase C in human breast cancer cells. J Steroid Biochem 1988;30:239-244
38. Holt MR, Koffer A. Cell motility: proline-rich proteins promote protrusions. Trends Cell Biol 2001;11:38-46. (Pubitemid 32056192)
39. Huang C, Rajfur Z, Yousefi N, Chen Z, Jacobson K, Ginsberg MH. Talin phosphorylation by Cdk5 regulates Smurf1-mediated talin head ubiquitylation and cell migration. Nat Cell Biol 2009;11:624-630
40. Zhu Y, Lin H, Li Z, Wang M, Luo J. Modulation of expression of ribosomal protein L7a (rpL7a) by ethanol in human breast cancer cells. Breast Cancer Res Treat 2001;69:29-38. (Pubitemid 33079027)
41. Sharma P, Sahni N, Tibshirani R, et al. Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res 2005;7:R634-R44.
42. Henry JL, Coggin DL, King CR. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2. Cancer Res 1993;53:1403-1408
43. Al-Maghrebi MAY, Anim JT, Olalu AA. Up-regulation of eukaryotic elongation factor-1 subunits in breast carcinoma. Anticancer Res 2005;25:2573-2577
44. Yahalom A, Kim TH, Winter E, Karniol B, von Arnim AG, Chamovitz DA. Arabidopsis eIF3e (INT-6) associates with both eIF3c and the COP9 signalosome subunit CSN7. J Biol Chem 2001;276:334-340 (Pubitemid 32050324)
45. Kim T-S, Kim HD, Kim J. PKC[δ]-dependent functional switch of rpS3 between translation and DNA repair. Biochimica et Biophysica Acta (BBA) - Mol Cell Res 2009;1793:395-405.
46. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19: 1720-1730 (Pubitemid 29098230)
47. Washburn MP, Koller A, Oshiro G, et al. Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomycescerevisiae. Proc Natl Acad Sci U S A 2003;100:3107-3112 (Pubitemid 36356547)
48. Luftner D, Mesterharm J, Akrivakis C, et al. Tumor type M2 pyruvate kinase expression in advanced breast cancer. Anticancer Res 2000; 20:5077-5082 (Pubitemid 32319084)
49. Jin W, Chen Y, Di GH, et al. Estrogen receptor (ER) β or p53 attenuates ERα-mediated transcriptional activation on the BRCA2 promoter. J Biol Chem 2008;283:29671-29680
50. Koga H, Matsui S, Hirota T, Takebayashi S, Okumura K, Saya H. A human homolog of Drosophila lethal(3)malignant brain tumor (l(3)mbt) protein associates with condensed mitotic chromosomes. Oncogene 1999;18:3799-3809